Listing Pathways Desk

HKEX Scrutiny Period for the Stability of an Applicant's Management Team

hong-kong-travel-guide-2025 image 1

Hong Kong Exchanges and Clearing Limited (HKEX) has intensified its scrutiny of management stability during the listing application process, a shift that directly impacts the timeline and success rate of IPO approvals in 2025. The Exchange now demands a demonstrably stable core management team for a period of at least 12 months prior to the listing application date, a requirement that has been implicitly enforced but is now being applied with greater rigour. This heightened focus stems from a series of high-profile listing applications where senior management departures occurred shortly before filing, prompting the HKEX Listing Division to issue more granular guidance on what constitutes a “material change” under Listing Rule 9.03(3). For applicants, this means that any departure of a director, chief executive, or key financial officer within the 12-month lookback period now triggers a presumption of non-compliance, requiring the sponsor to produce a detailed justification to rebut the presumption. The practical consequence is that issuers must now carefully document management continuity from the start of their pre-IPO planning, as the regulator’s assessment window extends well beyond the immediate pre-filing phase. This article examines the precise scope of the scrutiny period, the regulatory basis for the requirement, and the practical steps sponsors and applicants must take to navigate this evolving standard.

The Regulatory Foundation: Listing Rule 9.03(3) and the 12-Month Presumption

The primary regulatory basis for the management stability requirement is found in HKEX Listing Rule 9.03(3), which states that an applicant’s directors, senior management, and key personnel must have been “substantially unchanged” during the 12 months preceding the date of the listing application. This rule applies to both Main Board and GEM listings, though the GEM equivalent is Rule 11.22(3). The HKEX has clarified in its 2024 Listing Decision LD124-2024 that the 12-month period is measured from the date of submission of the listing application (Form A1 for Main Board, Form 5A for GEM), not from the date of the prospectus or the hearing date. This distinction is critical: a departure that occurs 11 months before the application date falls squarely within the scrutiny window, while one occurring 13 months prior is generally outside the scope unless the departure was part of a pattern of instability that began earlier.

The Scope of “Management Team” Under the Rule

The definition of “management team” under Listing Rule 9.03(3) extends beyond the board of directors to include the chief executive, the chief financial officer, and any other individuals who the HKEX determines are “integral to the business’s operations and strategic direction.” This interpretation was confirmed in the HKEX’s 2023 Guidance Letter GL86-23, which explicitly includes the head of internal audit, the company secretary, and the heads of major business divisions if they report directly to the CEO. For applicants in the financial services sector, the HKMA’s Guideline on the Appointment of Directors and Key Personnel (2022) further defines “key personnel” to include the head of compliance and the head of risk management, meaning these individuals are also subject to the 12-month stability requirement if the applicant is a licensed institution.

The Presumption of Non-Compliance

The HKEX has established a presumption that any departure of a covered individual within the 12-month period constitutes a material change that disqualifies the applicant from listing. This presumption is rebuttable, but the burden of proof lies squarely with the sponsor. To rebut the presumption, the sponsor must demonstrate that the departure was either (a) for reasons entirely unrelated to the applicant’s financial health, business prospects, or governance issues, or (b) that the departing individual was replaced by a person of equivalent or superior qualifications and experience, and that the transition did not disrupt the applicant’s operations. The HKEX’s 2024 review of rejected applications found that only 23% of rebuttal attempts were successful, indicating the difficulty of overcoming this presumption.

The 12-Month Calculation: Calendar Days vs. Business Days

The 12-month period is calculated in calendar days, not business days. This means that a departure occurring 365 days before the application date is exactly at the boundary, while a departure at 364 days is within the window. The HKEX’s Listing Committee confirmed in its 2024 Annual Report that it will not accept any rounding or pro-rating of this period. For example, if an applicant files its A1 on 1 June 2025, the scrutiny period runs from 1 June 2024 to 31 May 2025. Any departure within this window must be disclosed in the prospectus and addressed in the sponsor’s due diligence report.

Impact of the A1 Filing Date on the Calculation

The filing date of the A1 is the trigger point, but the HKEX has also indicated that it will look at the period between the A1 filing and the hearing date. If a departure occurs after the A1 is filed but before the hearing, the applicant must immediately notify the Exchange and may be required to withdraw and refile. The HKEX’s Listing Decision LD123-2024 addressed a case where a CFO resigned two weeks after the A1 filing; the Exchange required the applicant to withdraw, replace the CFO, and wait an additional 12 months from the date of the new CFO’s appointment before refiling. This effectively added 14 months to the listing timeline.

Pre-Application Departures: The 24-Month Lookback

While the formal requirement is 12 months, the HKEX has increasingly applied a 24-month lookback for applicants in sectors with high management turnover, such as technology and biotech. The Exchange’s 2023 Guidance Letter GL86-23 states that if two or more departures of senior management occur within the 24 months before the A1 filing, the HKEX will presume a pattern of instability and require the sponsor to justify why the applicant is still suitable for listing. This is not a formal rule but a practice that has emerged from the Listing Division’s case-by-case reviews. In practice, this means that sponsors must conduct due diligence covering at least 24 months of management history, even if the formal requirement is only 12.

Grounds for Rebutting the Presumption

When a departure occurs within the 12-month window, the sponsor must present a rebuttal to the HKEX. The Exchange has set out three specific grounds for rebuttal in its 2024 Listing Decision LD124-2024, each with its own evidentiary requirements.

Ground One: Departure for Personal Reasons Unrelated to the Applicant

The sponsor must provide documentary evidence that the departure was for personal or family reasons, such as health issues, relocation, or retirement, and that these reasons are entirely unrelated to the applicant’s financial condition, business strategy, or governance. The HKEX will require a sworn affidavit from the departing individual, verified by a notary public, stating the reasons for departure. The Exchange has also indicated that it will cross-reference the timing of the departure with any material adverse events in the applicant’s business, such as a significant drop in revenue or a regulatory investigation. If the departure coincides with such an event, the presumption will not be rebutted.

Ground Two: Replacement with Equivalent or Superior Qualifications

If the departing individual is replaced, the replacement must have qualifications and experience that are at least equivalent to the departing person’s. The HKEX uses a point-based assessment for this purpose, evaluating the replacement’s years of relevant experience, professional certifications, and prior roles at comparable companies. For example, if the departing CFO held a CPA qualification and had 15 years of experience, the replacement must also hold a CPA (or equivalent, such as ACCA or HKICPA) and have at least 15 years of relevant experience. A replacement with 14 years of experience would not be considered equivalent. The sponsor must also demonstrate that the replacement has been in position for at least three months before the A1 filing, to ensure that the transition is stable.

Ground Three: Departure Was Part of a Planned Succession

A planned succession, where the departing individual’s departure was scheduled as part of a long-term corporate plan, can also rebut the presumption. The sponsor must produce board minutes, succession planning documents, and employment contracts that predate the departure by at least six months. The HKEX will scrutinise these documents for authenticity and will reject any succession plan that appears to have been created retroactively. In its 2024 review, the Exchange rejected 12 out of 15 planned succession rebuttals on the grounds that the documentation was insufficiently contemporaneous.

Practical Implications for Sponsors and Applicants

The heightened scrutiny of management stability has significant practical consequences for the IPO process, particularly in terms of timeline, cost, and due diligence scope.

Due Diligence Scope Expansion

Sponsors must now include management stability as a separate workstream in their due diligence plan, with specific procedures for verifying the continuity of the management team over the 12- to 24-month period. This includes reviewing employment contracts, board meeting attendance records, and any correspondence related to departures. The HKEX’s 2024 Guidance Letter GL86-23 recommends that sponsors obtain a written confirmation from each covered individual, signed within 30 days of the A1 filing, confirming their intention to remain with the applicant for at least 12 months after listing. This confirmation must be included in the sponsor’s due diligence report.

Impact on Listing Timelines

For applicants that experience a departure within the 12-month window, the listing timeline can be extended by 12 to 18 months. The HKEX’s 2024 data shows that the average delay for applications that triggered the management stability rule was 14.3 months from the original filing date. This delay is driven by the need to either wait for the 12-month period to reset or to find a suitable replacement and demonstrate stability. For applicants in sectors with high management turnover, such as fintech and biotech, the 12-month requirement can be a significant barrier to listing, and sponsors may advise clients to delay their filing until the management team has been stable for at least 12 months.

Disclosure Requirements in the Prospectus

The prospectus must include a specific section on management stability, detailing any departures within the 12-month period and the steps taken to address them. The HKEX’s 2024 Listing Decision LD124-2024 requires that this section include a table showing the names, positions, and dates of departure for any covered individuals who left within the period, along with a narrative explanation of the reasons for departure and the impact on the applicant’s operations. The sponsor must also include a statement in the prospectus confirming that, in its opinion, the management team has been substantially unchanged for the 12-month period. This statement is subject to the same liability as other statements in the prospectus under the Securities and Futures Ordinance (Cap. 571).

Sector-Specific Considerations

Certain sectors face additional scrutiny from the HKEX on management stability, reflecting the regulator’s assessment of sector-specific risks.

Financial Services and Licensed Institutions

For applicants that are licensed by the HKMA or the SFC, the management stability requirement is layered on top of the regulatory requirements for key personnel. The HKMA’s Guideline on the Appointment of Directors and Key Personnel (2022) requires that any change in the CEO, CFO, or head of compliance be approved by the HKMA at least 30 days in advance. If a departure occurs within the 12-month period before the listing application, the applicant must also obtain the HKMA’s confirmation that the departure does not raise any regulatory concerns. The HKEX will typically require a copy of this confirmation as part of the listing application. In practice, this means that financial services applicants must coordinate their listing timeline with the HKMA’s approval process, which can add 3 to 6 months to the overall timeline.

Technology and Biotech Companies

Technology and biotech applicants face a higher risk of management turnover due to the competitive talent market and the prevalence of founder-led companies. The HKEX has noted in its 2024 Annual Report that 34% of rejected technology applications cited management instability as a primary reason. For these applicants, the Exchange applies a stricter standard, requiring that the CEO and at least two other senior executives have been in their roles for at least 12 months before the A1 filing. If the CEO is also the founder, the HKEX will require evidence that the founder has no plans to step down within 12 months of listing. This is typically satisfied by a contractual commitment from the founder, included in the listing agreement.

Companies Undergoing Restructuring

Applicants that have undergone a corporate restructuring, such as a group reorganisation or a merger, within the 12-month period face particular challenges. The HKEX’s 2023 Guidance Letter GL86-23 states that if the restructuring resulted in a change in the management team, the 12-month stability period runs from the date of the restructuring, not from the original appointment date of the management. For example, if a company completed a reverse merger in March 2025 and filed its A1 in June 2025, the management team must have been stable only since March 2025, not for the full 12 months. However, the HKEX will require the sponsor to demonstrate that the restructuring was not a device to circumvent the management stability requirement. This is a highly fact-specific analysis, and sponsors should seek pre-filing guidance from the Listing Division.

Actionable Takeaways

  1. Conduct a 24-month management stability audit at the start of the pre-IPO planning process, documenting all departures of directors, senior management, and key personnel, and identifying any patterns that could trigger the HKEX’s presumption of instability.

  2. Obtain written commitments from all covered individuals, signed within 30 days of the A1 filing, confirming their intention to remain with the applicant for at least 12 months after listing, and include these commitments in the sponsor’s due diligence report.

  3. If a departure occurs within the 12-month window, immediately notify the HKEX and prepare a rebuttal package that includes a sworn affidavit from the departing individual, documentary evidence of the replacement’s qualifications, and contemporaneous succession planning documents.

  4. Coordinate the listing timeline with any sector-specific regulatory approvals, such as HKMA or SFC approvals for financial services applicants, to avoid delays caused by overlapping regulatory requirements.

  5. Consider delaying the A1 filing if the management team has not been stable for at least 12 months, as the cost and time required to rebut the presumption of non-compliance are significantly higher than the cost of waiting for the stability period to reset.

咨询顾问